Updates are available Correction dated 2021-06-02
Click to view Correction: https://doi.org/10.1038/S41591-021-01412-8
-
Authors
Schneider, Jay W. http://orcid.org/0000-0002-7386-9343
Oommen, Saji http://orcid.org/0000-0001-6824-4894
Qureshi, Muhammad Y. http://orcid.org/0000-0002-9898-2318
Goetsch, Sean C.
Pease, David R. http://orcid.org/0000-0002-0472-1900
Sundsbak, Rhianna S.
Guo, Wei http://orcid.org/0000-0002-9158-8107
Sun, Mingming http://orcid.org/0000-0002-3117-7066
Sun, Han http://orcid.org/0000-0002-3390-0027
Kuroyanagi, Hidehito
Webster, Dennis A.
Coutts, Alexander W.
Holst, Kimberly A.
Edwards, Brooks S.
Newville, Nikolas
Hathcock, Matthew A.
Melkamu, Tamene
Briganti, Francesca http://orcid.org/0000-0001-5738-2642
Wei, Wu http://orcid.org/0000-0001-5643-8739
Romanelli, Maria G. http://orcid.org/0000-0002-7360-1195
Fahrenkrug, Scott C.
Frantz, Doug E. http://orcid.org/0000-0002-4509-4579
Olson, Timothy M.
Steinmetz, Lars M. http://orcid.org/0000-0002-3962-2865
Carlson, Daniel F. http://orcid.org/0000-0001-6095-2108
Nelson, Timothy J.
Peral, Susana Cantero
Edgerton, Sarah
Wobig, Joan
Rasmussen, Boyd
Scholz, Jodi A.
Cetta, Frank
Suddendorf, Scott H.
Pedersen, Joanne M.
Krage, Steve
Frisk, Craig S.
Reece, Chelsea L.
Miller, Angela R.
Martineau, Sara E.
Johnson, Rebecca K.
Breuer, Amanda L.
Fox, Janell K.
,
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (U01HL100404)
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (U54HD087351)
American Heart Association (19TPA34830072)
-
License Information
Text and Data Mining valid from 2020-11-01
Version of Record valid from 2020-11-01
-
More Information
Article History
Received: 16 May 2018
Accepted: 21 August 2020
First Online: 13 November 2020
Change Date: 2 June 2021
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/S41591-021-01412-8
Competing interests
: Generation of the RBM20<sup>R636S</sup> pig by gene-editing technology represents a collaborative partnership between Recombinetics (St. Paul, Minnesota), a commercial entity and Mayo Clinic in Rochester (Minnesota). T.M., A.W.C., D.A.W., D.F.C. and S.C.F. are shareholders in Recombinetics (St. Paul, Minnesota), which seeks to commercialize the RBM20<sup>R636S</sup> pig. The Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome at Mayo Clinic—the co-inventor of the RBM20<sup>R636S</sup> pig—maintains a profit-sharing agreement with Recombinetics regarding this gene-edited pig.
